Induction of glutathione content in murine melanocytes after transformation with c-H-ras oncogene.

No abstract is available for this paper.

• Publication year

  1991

• Venue

  Carcinogenesis

• Publication date

  1991-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1093/CARCIN/12.7.1319PMID 1712678
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• c-Ha-ras oncogene expression in immortalized human keratinocytes (HaCaT) alters growth potential in vivo but lacks correlation with malignancy.

  1990cited by this paper
• Tumor progression in the human melanocytic system.

  1989cited by this paper
• Induction of tumorigenicity and lack of in vitro growth requirement for 12-O-tetradecanoylphorbol-13-acetate by transfection of murine melanocytes with v-Ha-ras.

  1989cited by this paper
• Multifactorial resistance to adriamycin: relationship of DNA repair, glutathione transferase activity, drug efflux, and P-glycoprotein in cloned cell lines of adriamycin-sensitive and -resistant P388 leukemia.

  1988cited by this paper
• Effects of modulation of hepatic glutathione on biotransformation and covalent binding of aflatoxin B1 to DNA in the mouse.

  1988cited by this paper
• The ras oncogenes increase the intrinsic resistance of NIH 3T3 cells to ionizing radiation.

  1988cited by this paper
• Increased resistance to cis-diamminedichloroplatinum(II) in NIH 3T3 cells transformed by ras oncogenes.

  1988cited by this paper
• Purification and characterization of P-52 (glutathione S-transferase-P or 7-7) from normal liver and putative preneoplastic liver nodules.

  1988cited by this paper
• Aberrant oncogene expression in uncultured human sarcoma and melanoma.

  1987cited by this paper
• Drug resistance of cancer cells probed.

  1986cited by this paper
• Similar biochemical changes associated with multidrug resistance in human breast cancer cells and carcinogen-induced resistance to xenobiotics in rats.

  1986cited by this paper
• gamma-Glutamyl transpeptidase from kidney.

  1985cited by this paper
• Transforming ras genes from human melanoma: a manifestation of tumour heterogeneity?

  1984cited by this paper
• Malignant transformation of early passage rodent cells by a single mutated human oncogene

  1984cited by this paper
• Plasma glutathione and glutathione disulfide in the rat: regulation and response to oxidative stress.

  1983cited by this paper
• Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes

  1983cited by this paper
• Reduction in glutathione content of L-PAM resistant L1210 Cells confers drug sensitivity.

  1982cited by this paper
• Analysis of biological thiols: quantitative determination of thiols at the picomole level based upon derivatization with monobromobimanes and separation by cation-exchange chromatography.

  1981cited by this paper
• The selection and characterization of an invasive variant of the B16 melanoma.

  1979cited by this paper
• The resistance of putative premalignant liver cell populations, hyperplastic nodules, to the acute cytotoxic effects of some hepatocarcinogens.

  1976cited by this paper
• Glutathione S-transferases. The first enzymatic step in mercapturic acid formation.

  1974cited by this paper

• Importance of the trans-sulfuration pathway in cancer prevention and promotion

  2007cites this paper
• Glutathione in Cancer Biology and Therapy

  2006cites this paper
• Methylation and inhibition of expression of uPA by the RAS oncogene: divergence of growth control and invasion in breast cancer cells.

  2004cites this paper
• A free-radical hypothesis for the instability and evolution of genotype and phenotypein vitro

  2004cites this paper
• Growth-associated changes in glutathione content correlate with liver metastatic activity of B16 melanoma cells

  2004cites this paper
• Glutathione depletion-induced apoptosis of Ha-ras-transformed NIH3T3 cells can be prevented by melatonin

  2003cites this paper
• The use erythrocyte glutathione as a predictive marker for malignant melanoma.

  2000cites this paper
• Glutathione protects metastatic melanoma cells against oxidative stress in the murine hepatic microvasculature

  1998cites this paper
• Differences in expression of metalloproteinases and plasminogen activators in murine melanocytes and B16 melanoma variants: Lack of association with In vitro invasion

  1995cites this paper
• Genes regulating glutathione concentrations in X-ray-transformed rat embryo fibroblasts: changes in gamma-glutamylcysteine synthetase and gamma-glutamyltranspeptidase expression.

  1994cites this paper
• Effect of phosphotyrosine phosphatase over‐expression on glutathione metabolism in normal and oncogene‐transformed cells

  1994cites this paper
• [Drug resistance, oncogenes, and anti-oncogenes in epithelial tumors].

  1994cites this paper
• Ha-ras stimulates the transplasma membrane oxidoreductase activity of C3H10T1/2 cells.

  1993cites this paper
• Altered metabolism of glutathione in cells transformed by oncogenes which cause resistance to ionizing radiations

  1993cites this paper
• Resistance of human larynx carcinoma cells to cisplatin, gamma-irradiation and methotrexate does not involve overexpression of c-myc or c-Ki-ras oncogenes.

  1993cites this paper
• Multiple fractions of gamma rays do not induce overexpression of c-myc or c-Ki-ras oncogenes in human cervical carcinoma cells.

  1993cites this paper
• Reversed-phase chromatographic method for specific determination of glutathione in cultured malignant cells.

  1992cites this paper
• Differential sensitivities of murine melanocytes and melanoma cells to buthionine sulfoximine and anticancer drugs.

  1991cites this paper